Prognostic significance of Ki-67 (MIB-1) proliferation index in childhood primitive neuroectodermal tumors of the central nervous system

被引:0
|
作者
Grotzer, MA
Geoerger, B
Janss, AJ
Zhao, HQ
Rorke, LB
Phillips, PC
机构
[1] Childrens Hosp Philadelphia, Neurooncol Lab, Div Neurol & Oncol, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Div Biostat, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 2001年 / 36卷 / 02期
关键词
brain tumor; medulloblastoma; Ki-67; MIB-1; survival;
D O I
10.1002/1096-911X(20010201)36:2<268::AID-MPO1064>3.0.CO;2-F
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Primitive neuroectodermal tumors (PNET) of the central nervous system, including medulloblastomas, are the most common malignant brain tumors of childhood. Whereas some patients experience prolonged disease control after surgery and adjuvant therapy, others with tumors that appear com parable will relapse and eventually die from progressive disease. Procedure. Because proliferative activity may provide a potential correlate of biologic aggressiveness, PNETs of 78 well-characterized patients were evaluated by Ki-67 (MIB-1) immunohistochemistry. Proliferation indicts (PI) were determined by counting Ki-67 (MIB-1) positive tumor cells either in the highest staining region (hot spot PI), or in at least 15 randomly chosen fields (random PI). Results. Twenty-five of 78 PNETs showed amore than twofold higher value of hot spot PI (median 9.3%; range 0.6-56'%), compared to random PI (median 5.6%; range 0.2-41.3%). Univariate Cox regression analysis revealed that PNETs with a high hot spot PI had a significantly greater risk of progression and death than PNETs with a low hot spot PI (hazard ratio 1.58, P = 0.04). The hazard ratio remained significant after adjusting for M-stage in multivariate analysis. In contrast to hot spot PI, random PI proved not to be a significant prognostic predictor. Conclusions. Hot spot PI is a significant and independent prognostic factor in PNETs. Its assessment is uncomplicated, reliable, and may supplement routine histologic examination as a means for improving the accuracy of predicting the biologic behavior of childhood PNETs. Med. Pediatr. Oncol. 36:268-273, 2001. (C) 2001 Wiley-Liss. Inc.
引用
收藏
页码:268 / 273
页数:6
相关论文
共 50 条
  • [41] Pulmonary Carcinoid Tumors: A Prognostic Implications of Ki-67 Proliferative Index
    Langfort, R.
    Rudzinski, P.
    Szczepulska, E.
    Maksymiuk, B.
    Orlowski, T.
    Szolkowska, M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1937 - S1937
  • [42] Measurement of Ki-67 antigen in 159 pituitary adenomas using the MIB-1 monoclonal antibody
    Pizarro, CB
    Oliveira, MC
    Coutinho, LB
    Ferreira, NP
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2004, 37 (02) : 235 - 243
  • [43] A Computer Aided System for Calculation of Ki-67 Proliferation Index
    Ozkaraca, Osman
    Dere, Yelda
    Cetin, Gurcan
    Peker, Musa
    2017 INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE AND ENGINEERING (UBMK), 2017, : 580 - 585
  • [44] MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors
    Mittal, K
    Demopoulos, RI
    HUMAN PATHOLOGY, 2001, 32 (09) : 984 - 987
  • [45] Estrogen Receptor-Negative Breast Ductal Carcinoma: Clinicopathological Features and Mib-1 (Ki-67) Proliferative Index Association
    MdPaiman, Noorasmaliza
    Ali, Siti Aishah Md
    MdZin, Reena
    Kamal, Meor Zamari Meor
    Amin, Wan Anna Md
    Nallusamy, Mohan
    Puspanathan, Pavitratha
    Muhammad, Rohaizak
    Puteh, Sharifa Ezat Wan
    Das, Srijit
    PLOS ONE, 2014, 9 (02):
  • [46] PROGNOSTIC-SIGNIFICANCE OF IMMUNOHISTOCHEMICAL PROLIFERATION MARKERS (KI-67/MIB-1 AND PROLIFERATION-ASSOCIATED NUCLEAR ANTIGEN), P53 PROTEIN ACCUMULATION, AND NEOVASCULARIZATION IN CLINICAL STAGE-A NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS
    ALBERS, P
    ORAZI, A
    ULBRIGHT, TM
    MILLER, GA
    HAIDAR, JH
    DONOHUE, JP
    FOSTER, RS
    MODERN PATHOLOGY, 1995, 8 (05) : 492 - 497
  • [47] PROGNOSTIC ROLE OF KI-67 INDEX AND MITOTIC INDEX IN NEUROENDOCRINE TUMORS OF HETEROGENOUS ORIGIN
    Triveni, B.
    Kumar, Sandeep L.
    Mallikarjun, S. Sai
    Lakshmi, Sri
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2014, 3 (67): : 14438 - 14444
  • [48] Classification Model to Estimate MIB-1 (Ki 67) Proliferation Index in NSCLC Patients Evaluated With 18F-FDG-PET/CT
    Palumbo, Barbara
    Capozzi, Rosanna
    Bianconi, Francesco
    Fravolini, Mario Luca
    Cascianelli, Silvia
    Messina, Salvatore Gerardo
    Bellezza, Guido
    Sidoni, Angelo
    Puma, Francesco
    Ragusa, Mark
    ANTICANCER RESEARCH, 2020, 40 (06) : 3355 - 3360
  • [49] Pediatric Primitive Neuroectodermal Tumors of the Central Nervous System Differentially Express Granzyme Inhibitors
    Vermeulen, Jeroen F.
    van Hecke, Wim
    Spliet, Wim G. M.
    Hidalgo, Jose Villacorta
    Fisch, Paul
    Broekhuizen, Roel
    Bovenschen, Niels
    PLOS ONE, 2016, 11 (03):
  • [50] Ki-67 proliferation index - Correlation with prognostic parameters and outcome in multiple myeloma
    Alexandrakis, MG
    Passam, FH
    Kyriakou, DS
    Dambaki, K
    Niniraki, M
    Stathopoulos, E
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2004, 27 (01): : 8 - 13